Celgene approves buyback of up to $2.5 billion in stock
6/13/2012
(Reuters) - Celgene Corp said on Wednesday it authorized the supplementary
copyrights:cite this source roget's ii: the new lexicon
if (lexico_globals.googleafc.ads.content.length)
{
document.write(lexico_globals.googleafc.ads.contenttop);
document.write(lexico_globals.googleafc.ads.sponsoredlinks);
document.write(lexico_globals.googleafc.ads.content[2]);
document.write("") repurchase of up to $2.5 billion in common stock, productive immediately. In April, the biotechnology company said it repurchased about 2.35 million shares during the first qua...
More: - Continued here
Entry 1 of 19080
Last Page | Next Page










Report this!